[Soluble guanyl cyclases. Key enzymes for therapeutic applications of the NO principle].
Hönicka
M
M
DLR Institut für Luft- und Raumfahrtmedizin, Köln.
Gerzer
R
R
D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D005260:Female; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000502:physiology / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects / Q000502:physiology
D009569:Nitric Oxide; D006162:Guanylate Cyclase